2025-08-27T10:50:42-05:00 2024-12-31 462958029 MILLER GROSSBARD ADVISORS LLP 600 N SHEPHERD DR SUITE 200 HOUSTON TX 77007 990 2024-01-01 464518003 HOUSTON AORTIC FOUNDATION (FKA HOUSTON AORTIC SYMPOSIUM INC) HOUS 7134865100 6400 FANNIN ST STE 2850 HOUSTON TX 77030 HAZIM J SAFI MD DIRECTOR, PRESIDENT, TREASURER 7134865100 2025-08-04 1 0 ADAM BARR P01721847 7136223960 2025-08-03 2024 2025-03-06 01:10:19Z HAZIM J SAFI MD 6400 FANNIN ST STE 2850 HOUSTON TX 77030 500666 0 X HTTP://WWW.HOUSTONAORTICSYMPOSIUM.COM X 2015 TX TO HOLD AN ANNUAL SCIENTIFIC AND EDUCATIONAL MEETING ON TOPICS PERTINENT TO AORTIC DISEASE AND ITS TREATMENT. 6 6 0 0 0 0 410000 435961 80510 64705 0 0 0 0 490510 500666 0 0 0 0 0 0 0 0 0 434301 456786 434301 456786 56209 43880 421120 465000 0 0 421120 465000 SEE SCHEDULE O 0 0 456786 64705 THE HOUSTON AORTIC SYMPOSIUM MEETINGS OVER THE PRIOR THREE YEARS (2022, 2023, AND 2024) WOULD BE THE THREE LARGEST SERVICE ACCOMPLISHMENTS. 456786 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 X 6 6 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 0 0 0 0 0 X PROMEDICA INC 7607202263 300 CARLSBAD VILLAGE DR STE CARLSBAD CA 92008 X HAZIM J SAFI MD DIRECTOR, PRESIDENT, TREAS 0.00 X 0 0 0 CHARLES C MILLER III PHD DIRECTOR 0.00 X 0 0 0 ANTHONY L ESTRERA MD DIRECTOR, VICE PRESIDENT 0.00 X 0 0 0 KRISTOFER M CHARLTON-OUW MD DIRECTOR 0.00 X 0 0 0 KAMAL G KHALIL MD DIRECTOR 0.00 X 0 0 0 ALI AZIZZADEH MD DIRECTOR, SECRETARY 0.00 X 0 0 0 0 0 0 0 0 0 0 0 435961 435961 EVENT REGISTRATION 611710 64705 64705 64705 500666 64705 0 0 35024 35024 148436 148436 MEALS - MEETINGS 80368 80368 AUDIO VISUAL - MEETINGS 74202 74202 SCHEDULING AND SEMINAR 73490 73490 SUPPLIES - MEETINGS 16273 16273 28993 28993 456786 456786 0 0 409814 446586 11306 18414 421120 465000 0 0 X 0 0 0 0 421120 465000 421120 465000 421120 465000 43880 0 X 0 0 0 X 394850 423700 410000 435961 1664511 78679 66535 80510 64705 290429 473529 490235 490510 500666 1954940 0 0 0 1954940 473529 490235 490510 500666 1954940 1.00000 1.00000 0.00000 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED FORM 990, PART III, LINE 1, DESCRIPTION OF ORGANIZATION MISSION: THE CORPORATION SHALL ENGAGE IN ACTIVITIES INCLUDING, BUT NOT LIMITED TO, THE FOLLOWING: (I) PLANNING, SPONSORING, ORGANIZING, CONDUCTING, AND/OR HOSTING CERTAIN SCIENTIFIC AND EDUCATIONAL SYMPOSIUMS, CONFERENCES, AND OTHER POTENTIAL MEETINGS FOR THE PURPOSE OF EDUCATING MEDICAL DOCTORS AND PHYSICIANS AND OTHER MEDICAL RESEARCHERS AND HEALTH PROFESSIONALS ON THE LATEST RESEARCH AND DEVELOPMENTS IN THE PRIMARY PRACTICE AREA OF CARDIOVASCULAR DISEASE; (II) ORGANIZING, DEVELOPING, AND/OR SUSTAINING CERTAIN ACTIVITIES AND PROGRAMS (INCLUDING, BUT NOT LIMITED TO, THE "LIVING WITH VASCULAR DISEASE; ENGAGEMENT AND OUTREACH NETWORK OR "LIVE-ON") THAT PROVIDE SURVIVORSHIP SUPPORT TO PEOPLE WITH AORTIC DISEASE AND THEIR FAMILIES, FACILITATE PATIENT-EXPERT ENGAGEMENT AND EDUCATIONAL OPPORTUNITIES, AND GENERALLY ADVANCE RESEARCH AIMED AT UNDERSTANDING AND IMPROVING THE QUALITY OF LIFE AND CONDITION MANAGEMENT OF SUCH PATIENTS AND THEIR FAMILIES; AND (III) ANY AND ALL OTHER ACTIVITIES OR ENDEAVORS AS THE BOARD OF DIRECTORS OF THE CORPORATION MAY DEEM NECESSARY OR APPROPRIATE TO FURTHER SUCH PURPOSES. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS REVIEWED BY THE PRESIDENT. IT IS KEPT ON FILE FOR REVIEW BY ALL GOVERNING BODY OR GENERAL PUBLIC ON REQUEST FOR 3 YEARS. FORM 990, PART VI, SECTION B, LINE 12C BOARD MEMBERS MUST DISCLOSE CONFLICTS PRIOR TO ANY VOTE ON A CONTRACT OR TRANSACTION THAT MIGHT PRESENT A POTENTIAL CONFLICT AS STATED IN THE BYLAWS. DIRECTORS SHOULD PROVIDE WRITTEN DISCLOSURES ANNUALLY. FORM 990, PART VI, SECTION C, LINE 19 COPIES ARE AVAILABLE UPON REQUEST